• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗过敏性结膜炎的盐酸奥洛他定滴眼液

Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.

作者信息

Gonzalez-Estrada Alexei, Reddy Keerthi, Dimov Ves, Eidelman Frank

机构信息

a Division of Allergy and Clinical Immunology, Department of Medicine , East Tennessee Statement , Johnson City , TN , USA.

b Department of Pediatrics , East Tennessee Statement , Johnson City , TN , USA.

出版信息

Expert Opin Pharmacother. 2017 Aug;18(11):1137-1143. doi: 10.1080/14656566.2017.1346085. Epub 2017 Jul 9.

DOI:10.1080/14656566.2017.1346085
PMID:28656804
Abstract

Olopatadine hydrochloride is an antihistamine and mast cell stabilizer available as oral, intranasal and ocular preparations. Most of the practical applications of olopatadine therapy focus on the treatment of allergic rhinoconjunctivitis via intranasal and ocular routes. Areas covered: This article was created from a comprehensive literature search with information taken from meta-analyses, systematic reviews, and clinical trials of children and adults. The articles that have been selected, evaluate the use of intranasal and ocular antihistamines and their role in allergic rhinoconjunctivitis. Expert opinion: Olopatadine is significantly more effective than placebos in relieving the symptoms of allergic rhinoconjunctivitis. It can function both as a viable alternative or addition to first line therapies such as intranasal steroids and oral antihistamines.

摘要

盐酸奥洛他定是一种抗组胺药和肥大细胞稳定剂,有口服、鼻内和眼用制剂。奥洛他定治疗的大多数实际应用集中于通过鼻内和眼用途径治疗变应性鼻结膜炎。涵盖领域:本文通过全面的文献检索创作而成,信息取自儿童和成人的荟萃分析、系统评价及临床试验。所选文章评估了鼻内和眼用抗组胺药的使用及其在变应性鼻结膜炎中的作用。专家观点:奥洛他定在缓解变应性鼻结膜炎症状方面比安慰剂显著更有效。它既可以作为鼻内类固醇和口服抗组胺药等一线治疗的可行替代方案,也可以作为补充方案。

相似文献

1
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.用于治疗过敏性结膜炎的盐酸奥洛他定滴眼液
Expert Opin Pharmacother. 2017 Aug;18(11):1137-1143. doi: 10.1080/14656566.2017.1346085. Epub 2017 Jul 9.
2
Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis.奥洛他定治疗过敏性鼻炎和结膜炎的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1593-9. doi: 10.1517/17425255.2011.630389. Epub 2011 Oct 28.
3
Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.标题:奥洛他定治疗过敏性结膜炎的系统评价和荟萃分析。
Ocul Immunol Inflamm. 2017 Oct;25(5):663-677. doi: 10.3109/09273948.2016.1158282. Epub 2016 May 18.
4
Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.丙酸氟替卡松与奥洛他定联合用药对比丙酸氟替卡松与非索非那定联合用药治疗结膜变应原激发引起的变应性鼻结膜炎的疗效
Clin Ther. 2002 Jul;24(7):1161-74. doi: 10.1016/s0149-2918(02)80027-3.
5
Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.0.2% 奥洛他定滴眼液:首款每日一次给药的眼科抗过敏药物。
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):453-61. doi: 10.1517/17425255.4.4.453.
6
Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.使用结膜过敏原激发模型对两项研究进行联合分析,以评估一种具有双重活性的新型眼科抗过敏药物盐酸奥洛他定。
Am J Ophthalmol. 1998 Jun;125(6):797-804. doi: 10.1016/s0002-9394(98)00044-0.
7
A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.0.1%盐酸奥洛他定滴眼液与2%色甘酸钠滴眼液治疗季节性过敏性结膜炎的疗效及耐受性比较
Clin Ther. 2002 Oct;24(10):1561-75. doi: 10.1016/s0149-2918(02)80060-1.
8
A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.0.1% 奥洛他定滴眼液与安慰剂对照治疗季节性变应性结膜炎和鼻结膜炎体征及症状的随机、双盲、平行组比较
Clin Ther. 2003 Mar;25(3):931-47. doi: 10.1016/s0149-2918(03)80115-7.
9
Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.盐酸氮卓斯汀滴眼液经结膜注射雪松花粉过敏原激发试验对过敏性结膜炎的疗效
Ann Allergy Asthma Immunol. 2014 Oct;113(4):476-81. doi: 10.1016/j.anai.2014.07.007. Epub 2014 Aug 20.
10
A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.0.2%奥洛他定滴眼液与糠酸氟替卡松鼻喷雾剂治疗过敏性结膜炎的比较
Allergy Asthma Proc. 2008 Nov-Dec;29(6):644-53. doi: 10.2500/aap.2008.29.3176. Epub 2008 Dec 6.

引用本文的文献

1
Development of a Temperature and pH Dual-Sensitive In-Situ Gel for Treating Allergic Conjunctivitis.温度和 pH 双重敏感型原位凝胶治疗过敏性结膜炎的研制。
AAPS PharmSciTech. 2024 Sep 25;25(7):223. doi: 10.1208/s12249-024-02931-6.
2
Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.眼部发红 - 二:治疗结膜充血管理的治疗进展。
Ocul Surf. 2021 Jul;21:66-77. doi: 10.1016/j.jtos.2021.05.004. Epub 2021 May 15.
3
Relevance of IgE, allergy and eye rubbing in the pathogenesis and management of Keratoconus.
IgE、过敏及揉眼在圆锥角膜发病机制及治疗中的相关性
Indian J Ophthalmol. 2020 Oct;68(10):2067-2074. doi: 10.4103/ijo.IJO_1191_19.